Related Experiment Video
Updated: Aug 19, 2026

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
Quinazolinone as Bioactive Pharmacophore: Synthesis and Biological Activities
Mehak Aggarwal1, Shivali Sharma1, Divya Utreja1
1Department of Chemistry, College of Basic Sciences and Humanities, Punjab Agricultural University, Ludhiana, India.
None:
Quinazolinone, a nitrogen-containing bicyclic system having a benzene-fused pyrimidine ring, constitutes an important organic framework that has attracted the interest of all scientists working in the pharmacological and agricultural sectors owing to its numerous biological properties. Synthetic accessibility and structural flexibility allowed this skeleton to be easily modified with certain reagents that enhance its physicochemical properties. The aim of this review is to study the structural modifications of quinazolinone by various methods, suited for controlling virulence caused by various pathogens. Synthesis of quinazolinone derivatives and their potential hybrid skeletons with different heterocyclic moieties has also been explored. Furthermore, covering its applications from the well-established field of drug discovery to its innovative potential in crop protection, cancer treatment, microbial infections, insomnia, viral diseases, and so forth, has been reviewed with a concise discussion of their structure-activity relationships (SAR). In addition, it was deduced that modifying quinazolinone with electron-donating and electron-withdrawing substituents and heterocyclic moieties had escalated their biological aptitude in comparison to the basic quinazolinone moiety. This study can direct researchers working in this field to adopt a new approach for formulating and optimizing the synthesis and therapeutic potential of quinazolinone derivatives.
Related Concept Videos
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Bacterial DNA Synthesis
Antiviral Nucleoside Inhibitors

